Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease

US Patent 10632135 · Granted Apr 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multivalent fucose derivatives for use as a drug2022
Mannose derivatives useful for treating pathologies associated with adherent E. 2020
Mannose derivatives useful for treating pathologies associated with adherent E. 2020
Mannose derivatives useful for treating pathologies associated with adherent E. 2020
Mannose derivatives useful for treating pathologies associated with adherent E. 2020
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019
Orally available compounds, a process for preparing the same and their uses as a2019